Vertex Pharmaceuticals Inc (VRTX) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Vertex Pharmaceuticals Inc Company Snapshot

Business Description:

Vertex Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of diseases. The Company is engaged in phase-I clinical trials and/or nonclinical activities with respect to a range of additional drug candidates, including compounds intended for the treatment of hepatitis C virus (HCV) infection, cystic fibrosis (CF) and influenza. In November 2010, the Company submitted a new drug application (NDA), requesting approval to market telaprevir in the United States for the treatment of patients with chronic HCV infection. In our complete report available for purchase the company is compared to: Synta Pharmaceuticals Corp, China Sky One Medical, Incorporation and ISTA Pharmaceuticals, Inc..

Vertex Pharmaceuticals Inc

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 36.78
(Figures in U.S. Dollars)

1 Week	2.2%	13 Weeks	8.0%

4 Weeks	0.4%	52 Weeks	-6.8%

Vertex Pharmaceuticals Inc Key Data:

Ticker:	VRTX	Country:	UNITED STATES

Exchanges:	NAS FRA	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	1,410,626,000 (Year Ending Jan 2012).	Employees:	1,691

Currency:	U.S. Dollars	Market Cap:	7,698,201,120

Fiscal Yr Ends:	December	Shares Outstanding:	209,304,000

Share Type:	Common	Closely Held Shares:	2,163,706

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.